| Neuropsychological study | Structural Neuroimaging study | Molecular Neuroimaging study | |||
---|---|---|---|---|---|---|
 | p | c | p | c | P | c |
Any significant neurologic disease, such as Parkinson's disease, multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma followed by persistent neurologic defaults or known structural brain abnormalities. | X | X | X | X | X | X |
Any significant systemic illness or unstable medical condition | X | X | X | X | X | X |
History of significant head trauma followed by loss of consciousness | Â | Â | X | X | Â | Â |
Presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments or foreign objects in the eyes, skin or body. | Â | Â | X | X | Â | Â |
Claustrophobia | Â | Â | X | X | Â | Â |
Current use of psychoactive medications such as antidepressants, neuroleptics, anxiolytics or sedative hypnotics and mood stabilizers. | Â | Â | X | X | X | X |
History of the following psychiatric disorders: schizophrenia, schizoaffective disorder, delusional disorder, bipolar affective disorder and depressive disorder with psychotic features (DSM IV criteria) | X | X | X | X | X | X |
Tremor or dystonia in the cephalic region that unable the scanning procedure for imaging acquisition | Â | Â | X | X | X | X |